Expression of concern: Calcium plus vitamin D supplementation influences biomarkers of inflammation and oxidative stress in overweight and vitamin D-deficient women with polycystic ovary syndrome: A randomized double-blind placebo-controlled clinical trial (Clin Endocrinol (Oxf), 83, 6, (888-894), 10.1111/cen.12840);Calcium plus vitamin D supplementation influences biomarkers of inflammation and oxidative stress in overweight and vitamin D-deficient women with polycystic ovary syndrome: A randomized double-blind placebo-controlled clinical trial

Clinical Endocrinology

Volumn 83, Issue 6, 2015, Pages 888-894

  Foroozanfard, Fatemeh ^a   Jamilian, Mehri ^b   Bahmani, Fereshteh ^a   Talaee, Rezvan ^a   Talaee, Naeeme ^a   Hashemi, Teibeh ^a   Nasri, Khadijeh ^b   Asemi, Zatollah ^a   Esmaillzadeh, Ahmad ^c,d  

^a KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ARAK UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CALCIUM; CATALASE; GLUTATHIONE; MALONALDEHYDE; NITRIC OXIDE; PLACEBO; VITAMIN D; ANTIOXIDANT; BIOLOGICAL MARKER;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INTERVENTION STUDY; INVESTIGATIVE PROCEDURES; MAJOR CLINICAL STUDY; METABOLIC PARAMETERS; OBESITY; OVARY POLYCYSTIC DISEASE; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TOTAL ANTIOXIDANT CAPACITY; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; ADOLESCENT; BLOOD; DIETARY SUPPLEMENT; DRUG EFFECTS; METABOLISM; POLYCYSTIC OVARY SYNDROME; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIOXIDANTS; BIOMARKERS; C-REACTIVE PROTEIN; CALCIUM; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; GLUTATHIONE; HUMANS; OVERWEIGHT; OXIDATIVE STRESS; POLYCYSTIC OVARY SYNDROME; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84937686448     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.14892     Document Type: Erratum

References (35)

1. Gozdemir, E., Kaygusuz, I., &, Kafali, H., (2013) Is hepcidin a new cardiovascular risk marker in polycystic ovary syndrome? Gynecologic and Obstetric Investigation, 75, 196-202.
2. Hilali, N., Vural, M., Camuzcuoglu, H., et al,. (2013) Increased prolidase activity and oxidative stress in PCOS. Clinical Endocrinology (Oxf), 79, 105-110.
3. Gonzalez, F., Nair, K.S., Daniels, J.K., et al,. (2012) Hyperandrogenism sensitizes leukocytes to hyperglycemia to promote oxidative stress in lean reproductive-age women. Journal of Clinical Endocrinology and Metabolism, 97, 2836-2843.
4. Marciniak, A., Nawrocka-Rutkowska, J., Wisniewska, B., et al,. (2013) Chronic inflammation and metabolic syndrome in comparison with other signs belonging to the image of polycystic ovary syndrome. Polski Merkuriusz Lekarski, 34, 228-231.
5. Stepto, N.K., Cassar, S., Joham, A.E., et al,. (2013) Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp. Human Reproduction, 28, 777-784.
6. Oh, J.Y., Lee, J.A., Lee, H., et al,. (2009) Serum C-reactive protein levels in normal-weight polycystic ovary syndrome. Korean Journal of Internal Medicine, 24, 350-355.
7. Caserta, D., Adducchio, G., Picchia, S., et al,. (2014) Metabolic syndrome and polycystic ovary syndrome: an intriguing overlapping. Gynecological Endocrinology, 24, 397-402.
8. Mazloomi, S., Sharifi, F., Hajihosseini, R., et al,. (2012) Association between Hypoadiponectinemia and low serum concentrations of calcium and vitamin D in women with polycystic ovary syndrome. ISRN Endocrinology, 2012, 949427.
9. Lerchbaum, E., &, Obermayer-Pietsch, B., (2012) Vitamin D and fertility: a systematic review. European Journal of Endocrinology, 166, 765-778.
10. Firouzabadi, R., Aflatoonian, A., Modarresi, S., et al,. (2012) Therapeutic effects of calcium & vitamin D supplementation in women with PCOS. Complementary Therapies in Clinical Practice, 18, 85-88.
11. Pal, L., Berry, A., Coraluzzi, L., et al,. (2012) Therapeutic implications of vitamin D and calcium in overweight women with polycystic ovary syndrome. Gynecological Endocrinology, 28, 965-968.
12. Asemi, Z., Hashemi, T., Karamali, M., et al,. (2013) Effects of vitamin D supplementation on glucose metabolism, lipid concentrations, inflammation, and oxidative stress in gestational diabetes: a double-blind randomized controlled clinical trial. American Journal of Clinical Nutrition, 98, 1425-1432.
13. Rogoveanu, O.C., Mogosanu, G.D., Bejenaru, C., et al,. (2015) Effects of calcium fructoborate on levels of C-reactive protein, total cholesterol, low-density lipoprotein, triglycerides, IL-1beta, IL-6, and MCP-1: a double-blind, placebo-controlled clinical study. Biological Trace Element Research, 163, 124-131.
14. Asemi, Z., Samimi, M., Heidarzadeh, Z., et al,. (2012) A randomized controlled clinical trial investigating the effect of calcium supplement plus low-dose aspirin on hs-CRP, oxidative stress and insulin resistance in pregnant women at risk for pre-eclampsia. Pakistan Journal of Biological Sciences, 15, 469-476.
15. Asemi, Z., Samimi, M., Tabassi, Z., et al,. (2013) Vitamin D supplementation affects serum high-sensitivity C-reactive protein, insulin resistance, and biomarkers of oxidative stress in pregnant women. Journal of Nutrition, 143, 1432-1438.
16. Nair-Shalliker, V., Armstrong, B.K., &, Fenech, M., (2012) Does vitamin D protect against DNA damage? Mutation Research, 733, 50-57.
17. Hajsadeghi, S., Hejrati, M., Moghadami, S., et al,. (2012) Dilated cardiomyopathy in two patients with xeroderma pigmentosum disease: a case report. Acta Medica Iranica, 50, 147-150.
18. Sandhu, M.S., &, Casale, T.B., (2010) The role of vitamin D in asthma. Annals of Allergy, Asthma & Immunology 105, 191-199; quiz 200-192, 217.
19. Asemi, Z., Karamali, M., &, Esmaillzadeh, A., (2014) Effects of calcium-vitamin D co-supplementation on glycaemic control, inflammation and oxidative stress in gestational diabetes: a randomised placebo-controlled trial. Diabetologia, 57, 1798-1806.
20. Tabesh, M., Azadbakht, L., Faghihimani, E., et al,. (2014) Calcium-vitamin d cosupplementation influences circulating inflammatory biomarkers and adipocytokines in vitamin d-insufficient diabetics: a randomized controlled clinical trial. Journal of Clinical Endocrinology and Metabolism, 99, E2485-E2493.
21. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and Sterility, 81, 19-25.
22. Ramezani Tehrani, F., Minooee, S., &, Azizi, F., (2014) Validation of a simplified method to assess hirsutism in the Iranian population. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 174, 91-95.
23. Zittermann, A., Frisch, S., Berthold, H.K., et al,. (2009) Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. American Journal of Clinical Nutrition, 89, 1321-1327.
24. Chandler, P.D., Scott, J.B., Drake, B.F., et al,. (2014) Impact of vitamin d supplementation on inflammatory markers in African Americans: results of a four-arm, randomized, placebo-controlled trial. Cancer Prevention Research (Philadelphia, Pa.), 7, 218-225.
25. Jorde, R., Sneve, M., Torjesen, P.A., et al,. (2010) No effect of supplementation with cholecalciferol on cytokines and markers of inflammation in overweight and obese subjects. Cytokine, 50, 175-180.
26. von Hurst, P.R., Stonehouse, W., &, Coad, J., (2010) Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient-a randomised, placebo-controlled trial. British Journal of Nutrition, 103, 549-555.
27. Brandi, L., (2008) 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol-an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Danish Medical Bulletin, 55, 186-210.
28. Mauricio, D., Mandrup-Poulsen, T., &, Nerup, J., (1996) Vitamin D analogues in insulin-dependent diabetes mellitus and other autoimmune diseases: a therapeutic perspective. Diabetes/Metabolism Reviews, 12, 57-68.
29. Ekici, F., Ozyurt, B., &, Erdogan, H., (2009) The combination of vitamin D3 and dehydroascorbic acid administration attenuates brain damage in focal ischemia. Neurological Sciences, 30, 207-212.
30. Jain, S.K., &, Micinski, D., (2013) Vitamin D upregulates glutamate cysteine ligase and glutathione reductase, and GSH formation, and decreases ROS and MCP-1 and IL-8 secretion in high-glucose exposed U937 monocytes. Biochemical and Biophysical Research Communications, 437, 7-11.
31. Gupta, S., Ghulmiyyah, J., Sharma, R., et al,. (2014) Power of proteomics in linking oxidative stress and female infertility. BioMed Research International, 2014, 916212.
32. Lahucky, R., Bahelka, I., Kuechenmeister, U., et al,. (2007) Effects of dietary supplementation of vitamins D(3) and E on quality characteristics of pigs and longissimus muscle antioxidative capacity. Meat Science, 77, 264-268.
33. Hahn, M., Conterato, G.M., Frizzo, C.P., et al,. (2008) Effects of bone disease and calcium supplementation on antioxidant enzymes in postmenopausal women. Clinical Biochemistry, 41, 69-74.
34. Kallay, E., Bareis, P., Bajna, E., et al,. (2002) Vitamin D receptor activity and prevention of colonic hyperproliferation and oxidative stress. Food and Chemical Toxicology, 40, 1191-1196.
35. Ermak, G., &, Davies, K.J., (2002) Calcium and oxidative stress: from cell signaling to cell death. Molecular Immunology, 38, 713-721.